Related Experiment Video
Updated: Mar 30, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
3.3K
[Sleep Medicine: 1965 to 2015]
1Université de Montréal; Centre d'Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Coeur de Montréal.
Sante Mentale Au Quebec
|November 13, 2015
Summary
The Center for Advanced Research in Sleep Medicine (CARSM) has pioneered sleep disorder diagnostics and treatments for 40 years. Their research spans narcolepsy, RLS, and RBD, impacting global sleep medicine.
Area of Science:
- Sleep Medicine
- Neuroscience
- Chronobiology
Context:
- Established 40 years ago, the Center for Advanced Research in Sleep Medicine (CARSM) is a leading global institution.
- CARSM operates a 1,500 sq meter facility with specialized units for fundamental and clinical sleep research, chronobiology, and a sleep disorders clinic.
- The center integrates basic and clinical research with patient care, fostering a multidisciplinary approach.
Purpose:
- To detail the historical contributions and current research scope of CARSM in sleep medicine.
- To highlight CARSM's role in developing diagnostic tools and treatment strategies for various sleep disorders.
- To showcase CARSM's global collaborations and its focus on understanding the genetic and physiological underpinnings of sleep conditions.
Summary:
- CARSM has significantly advanced the understanding and diagnosis of sleep disorders, including narcolepsy, nocturnal epilepsy, sleep bruxism, restless legs syndrome (RLS), sleepwalking, and REM sleep behavior disorder (RBD).
- Pioneered diagnostic methods such as the multiple sleep latency test for narcolepsy, specialized EEG for nocturnal epilepsy, and polygraphic diagnosis for RBD.
- Conducted foundational epidemiological studies on RLS and sleep bruxism, and investigated the impact of sleep disorders on cognitive and cardiovascular health.
Impact:
- CARSM's research has led to the development of novel diagnostic tools and treatments, particularly dopaminergic therapies for RLS.
- Current research focuses on identifying prodromal markers for Parkinson disease and dementia in RBD patients, aiming to facilitate neuroprotective agent trials.
- CARSM's work has established it as a pivotal center for basic and clinical sleep research, influencing sleep medicine worldwide.
Related Concept Videos
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
848
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
848
01:23Sedatives and Hypnotics: Overview
2.0K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.0K
01:19Management of Insomnia
778
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
778
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
1.2K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.2K
01:20Sedatives and Hypnotics Drugs: Barbiturates
1.4K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.4K
01:17Sleepwalking and Sleep Talking
1.4K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.4K